Live Breaking News & Updates on News ratings for recursion pharmaceuticals daily

Stay informed with the latest breaking news from News ratings for recursion pharmaceuticals daily on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in News ratings for recursion pharmaceuticals daily and stay connected to the pulse of your community

Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) Director Sells $87,684.02 in Stock

Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX – Get Free Report) Director Blake Borgeson sold 11,447 shares of the stock in a transaction on Tuesday, April 16th. The shares were sold at an average price of $7.66, for a total transaction of $87,684.02. Following the completion of the sale, the director now directly owns 7,229,861 shares in the […]

Canada , China , Blake-borgeson , First-horizon-advisors-inc , Nasdaq , Quarter-for-recursion-pharmaceuticals , Recursion-pharmaceuticals-stock-performance , Recursion-pharmaceuticals , Needham-company , National-bank , Securities-exchange-commission , China-universal-asset-management-co

Cherry Creek Investment Advisors Inc. Acquires Shares of 17,853 Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX)

Cherry Creek Investment Advisors Inc. bought a new stake in Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX – Free Report) in the 4th quarter, according to its most recent filing with the SEC. The fund bought 17,853 shares of the company’s stock, valued at approximately $176,000. Other large investors have also recently made changes to their positions in […]

China , Tina-marriott-larson , Christopher-gibson , Recursion-pharmaceuticals , Cherry-creek-investment-advisors-inc , Recursion-pharmaceuticals-inc , Advisor-group , Baldwin-brothers , Insider-transactions-at-recursion-pharmaceuticals , Recursion-pharmaceuticals-company-profile , Recursion-pharmaceuticals-stock-down , Quarter-for-recursion-pharmaceuticals

Recursion Pharmaceuticals (NASDAQ:RXRX) Shares Gap Down Following Insider Selling

Recursion Pharmaceuticals (NASDAQ:RXRX) Shares Gap Down Following Insider Selling
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Canada , Tina-marriott-larson , News-ratings-for-recursion-pharmaceuticals-daily , Nasdaq , National-bank , Vident-investment-advisory , Recursion-pharmaceuticals-inc , Baldwin-brothers , Institutional-trading-of-recursion-pharmaceuticals , Ameritas-investment-partners-inc , Recursion-pharmaceuticals-stock-down , Keycorp

Insider Selling: Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) COO Sells $86,000.00 in Stock

Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX – Get Free Report) COO Tina Marriott sold 8,000 shares of the company’s stock in a transaction on Thursday, March 21st. The shares were sold at an average price of $10.75, for a total value of $86,000.00. Following the completion of the sale, the chief operating officer now directly owns 639,982 […]

Tina-marriott , Institutional-investors-weigh-in-on-recursion-pharmaceuticals , Recursion-pharmaceuticals-stock-performance , News-ratings-for-recursion-pharmaceuticals-daily , Keycorp , Quarter-for-recursion-pharmaceuticals , Needham-company , Vanguard-group-inc , Recursion-pharmaceuticals , Mubadala-investment-co , Goldman-sachs-group-inc , Securities-exchange-commission

Tina Marriott Sells 8,000 Shares of Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) Stock

Tina Marriott Sells 8,000 Shares of Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) Stock
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

China , Canada , Tina-marriott , First-horizon-advisors-inc , Recursion-pharmaceuticals-trading-down , Securities-exchange-commission , Recursion-pharmaceuticals-inc , Quarter-for-recursion-pharmaceuticals , News-ratings-for-recursion-pharmaceuticals-daily , Keycorp , Comerica-bank , Recursion-pharmaceuticals-company-profile

Recursion Pharmaceuticals (NASDAQ:RXRX) Stock Price Down 5.9% After Insider Selling

Recursion Pharmaceuticals (NASDAQ:RXRX) Stock Price Down 5.9% After Insider Selling
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Tina-marriott-larson , Christopher-gibson , Recursion-pharmaceuticals-price-performance , Mubadala-investment-co , Recursion-pharmaceuticals , Blackrock-inc , Recursion-pharmaceuticals-company-profile , Securities-exchange-commission , Hedge-funds-weigh-in-on-recursion-pharmaceuticals , News-ratings-for-recursion-pharmaceuticals-daily , Vanguard-group-inc , Needham-company

Insider Selling: Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) CEO Sells $430,743.34 in Stock

Insider Selling: Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) CEO Sells $430,743.34 in Stock
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Canada , Christopher-gibson , Quarter-for-recursion-pharmaceuticals , News-ratings-for-recursion-pharmaceuticals-daily , Recursion-pharmaceuticals-inc , Recursion-pharmaceuticals , Nasdaq , Principal-financial-group-inc , Baldwin-brothers , Ameritas-investment-partners-inc , Recursion-pharmaceuticals-company-profile , Recursion-pharmaceuticals-stock-performance

Recursion Pharmaceuticals (NASDAQ:RXRX) Shares Down 6.1% After Insider Selling

Shares of Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX – Get Free Report) dropped 6.1% during trading on Monday after an insider sold shares in the company. The company traded as low as $10.50 and last traded at $10.51. Approximately 3,359,534 shares traded hands during trading, a decline of 54% from the average daily volume of 7,262,308 shares. […]

Christopher-gibson , Michael-secora , Recursion-pharmaceuticals-company-profile , Securities-exchange-commission , Recursion-pharmaceuticals , Nasdaq , Recursion-pharmaceuticals-stock-performance , Jpmorgan-chase-co , Needham-company , Sumitomo-mitsui-trust-holdings-inc , News-ratings-for-recursion-pharmaceuticals-daily , Nvidia-corp

Recursion Pharmaceuticals (NASDAQ:RXRX) Trading Down 6.1% on Insider Selling

Shares of Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX – Get Free Report) dropped 6.1% during trading on Monday following insider selling activity. The stock traded as low as $10.50 and last traded at $10.51. Approximately 3,359,534 shares changed hands during trading, a decline of 54% from the average daily volume of 7,262,308 shares. The stock had previously […]

Canada , Blake-borgeson , Tina-marriott , News-ratings-for-recursion-pharmaceuticals-daily , Keycorp , Manufacturers-life-insurance-company , National-bank , Recursion-pharmaceuticals-inc , Recursion-pharmaceuticals , Securities-exchange-commission , Recursion-pharmaceuticals-company-profile , Needham-company

Recursion Pharmaceuticals (NASDAQ:RXRX) Shares Down 6.1% After Insider Selling

Shares of Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX – Get Free Report) dropped 6.1% during trading on Monday after an insider sold shares in the company. The company traded as low as $10.50 and last traded at $10.51. Approximately 3,359,534 shares traded hands during trading, a decline of 54% from the average daily volume of 7,262,308 shares. […]

Christopher-gibson , Michael-secora , Recursion-pharmaceuticals-company-profile , Recursion-pharmaceuticals , Securities-exchange-commission , Needham-company , Nasdaq , Recursion-pharmaceuticals-stock-performance , Jpmorgan-chase-co , Nvidia-corp , News-ratings-for-recursion-pharmaceuticals-daily , Keycorp